share_log

HC Wainwright & Co. Initiates Coverage On Corvus Pharma With Buy Rating, Announces Price Target of $11

HC Wainwright & Co. Initiates Coverage On Corvus Pharma With Buy Rating, Announces Price Target of $11

HC Wainwright & Co. 开始对 Corvus Pharma 进行覆盖,给予买入评级,宣布目标价格为 11 美元
Benzinga ·  01/02 07:00  · 评级/大行评级

HC Wainwright & Co. analyst Sean Lee initiates coverage on Corvus Pharma (NASDAQ:CRVS) with a Buy rating and announces Price Target of $11.

HC Wainwright & Co. 分析师Sean Lee 对Corvus Pharma (纳斯达克:CRVS)启动了覆盖,给予买入评级,并宣布目标价为11美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发